Roanoke Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.29M | Hold |
4,145
| – | – | 0.44% | 52 |
|
|
2024
Q4 | $1.08M | Sell |
4,145
-10
| -0.2% | -$2.97K | 0.35% | 56 |
|
|
2024
Q3 | $1.34M | Hold |
4,155
| – | – | 0.42% | 54 |
|
|
2024
Q2 | $1.3M | Hold |
4,155
| – | – | 0.43% | 54 |
|
|
2024
Q1 | $1.18M | Buy |
4,155
+690
| +20% | +$202K | 0.39% | 54 |
|
|
2023
Q4 | $998K | Buy |
3,465
+100
| +3% | +$27.2K | 0.37% | 55 |
|
|
2023
Q3 | $904K | Buy |
3,365
+675
| +25% | +$168K | 0.37% | 57 |
|
|
2023
Q2 | $597K | Hold |
2,690
| – | – | 0.24% | 65 |
|
|
2023
Q1 | $650K | Hold |
2,690
| – | – | 0.28% | 63 |
|
|
2022
Q4 | $707K | Hold |
2,690
| – | – | 0.32% | 62 |
|
|
2022
Q3 | $606K | Hold |
2,690
| – | – | 0.29% | 62 |
|
|
2022
Q2 | $654K | Hold |
2,690
| – | – | 0.29% | 64 |
|
|
2022
Q1 | $650K | Sell |
2,690
-8,718
| -76% | -$2M | 0.24% | 68 |
|
|
2021
Q4 | $2.57M | Sell |
11,408
-65
| -0.6% | -$13.7K | 0.85% | 40 |
|
|
2021
Q3 | $2.44M | Sell |
11,473
-290
| -2% | -$66.7K | 0.87% | 40 |
|
|
2021
Q2 | $2.87M | Buy |
11,763
+2,035
| +21% | +$501K | 1% | 35 |
|
|
2021
Q1 | $2.42M | Sell |
9,728
-15
| -0.2% | -$3.58K | 1.05% | 34 |
|
|
2020
Q4 | $2.24M | Sell |
9,743
-130
| -1% | -$30K | 1.06% | 33 |
|
|
2020
Q3 | $2.51M | Buy |
9,873
+10
| +0.1% | +$2.48K | 1.37% | 24 |
|
|
2020
Q2 | $2.33M | Sell |
9,863
-1,061
| -10% | -$242K | 1.35% | 28 |
|
|
2020
Q1 | $2.21M | Sell |
10,924
-65
| -0.6% | -$14.2K | 1.49% | 25 |
|
|
2019
Q4 | $2.65M | Sell |
10,989
-2,655
| -19% | -$585K | 1.32% | 29 |
|
|
2019
Q3 | $2.64M | Sell |
13,644
-65
| -0.5% | -$12.5K | 1.23% | 27 |
|
|
2019
Q2 | $2.53M | Sell |
13,709
-10
| -0.1% | -$1.79K | 1.14% | 29 |
|
|
2019
Q1 | $2.61M | Sell |
13,719
-50
| -0.4% | -$9.55K | 1.21% | 27 |
|
|
2018
Q4 | $2.68M | Sell |
13,769
-220
| -2% | -$42.9K | 1.42% | 24 |
|
|
2018
Q3 | $2.9M | Sell |
13,989
-9
| -0.1% | -$1.77K | 1.3% | 31 |
|
|
2018
Q2 | $2.58M | Sell |
13,998
-1,070
| -7% | -$189K | 1.24% | 29 |
|
|
2018
Q1 | $2.57M | Sell |
15,068
-4,425
| -23% | -$812K | 1.24% | 32 |
|
|
2017
Q4 | $3.39M | Sell |
19,493
-1,975
| -9% | -$350K | 1.62% | 17 |
|
|
2017
Q3 | $4M | Sell |
21,468
-2,225
| -9% | -$394K | 1.89% | 15 |
|
|
2017
Q2 | $4.08M | Sell |
23,693
-1,275
| -5% | -$207K | 1.93% | 16 |
|
|
2017
Q1 | $4.1M | Sell |
24,968
-6,025
| -19% | -$1M | 1.95% | 14 |
|
|
2016
Q4 | $4.53M | Sell |
30,993
-8,835
| -22% | -$1.33M | 2.06% | 13 |
|
|
2016
Q3 | $6.64M | Sell |
39,828
-1,105
| -3% | -$187K | 3% | 5 |
|
|
2016
Q2 | $6.23M | Sell |
40,933
-137
| -0.3% | -$21.3K | 2.89% | 6 |
|
|
2016
Q1 | $6.16M | Buy |
41,070
+6,332
| +18% | +$941K | 2.85% | 5 |
|
|
2015
Q4 | $5.64M | Sell |
34,738
-12,045
| -26% | -$1.89M | 2.41% | 9 |
|
|
2015
Q3 | $6.47M | Sell |
46,783
-1,300
| -3% | -$205K | 2.38% | 9 |
|
|
2015
Q2 | $7.38M | Buy |
48,083
+930
| +2% | +$149K | 2.38% | 11 |
|
|
2015
Q1 | $7.54M | Sell |
47,153
-25
| -0.1% | -$3.94K | 2.47% | 12 |
|
|
2014
Q4 | $7.51M | Buy |
47,178
+5,750
| +14% | +$896K | 2.58% | 7 |
|
|
2014
Q3 | $5.82M | Sell |
41,428
-4,680
| -10% | -$611K | 2.39% | 11 |
|
|
2014
Q2 | $5.46M | Buy |
46,108
+4,850
| +12% | +$561K | 2.09% | 15 |
|
|
2014
Q1 | $5.09M | Buy |
41,258
+100
| +0.2% | +$12.1K | 2.24% | 14 |
|
|
2013
Q4 | $4.7M | Buy |
41,158
+5
| +0% | +$569 | 2.16% | 13 |
|
|
2013
Q3 | $4.67M | Buy |
+41,153
| New | +$4.46M | 2.27% | 11 |
|
Other funds holding AMGN
Roanoke Asset Management's AMGN Position: Q1 2025 in Review
Roanoke Asset Management held its Amgen (AMGN) position steady in Q1 2025 at 4,145 shares worth $1.29M. The position accounts for 0.44% of the portfolio, ranked #52.
Roanoke Asset Management first reported a position in AMGN in Q3 2013 and has held it in 47 quarters since. The position peaked at $7.54M in Q1 2015. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Roanoke Asset Management held 4,145 shares of Amgen worth $1.29M as of Q1 2025.
- Roanoke Asset Management left its Amgen share count unchanged in Q1 2025.
- Amgen made up 0.44% of Roanoke Asset Management's portfolio in Q1 2025, its #52 holding.
- Roanoke Asset Management first reported a position in Amgen in Q3 2013 and has held it in 47 quarters since.
- Roanoke Asset Management's Amgen position peaked at $7.54M in Q1 2015.
- 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Roanoke Asset Management's 13F filing for Q1 2025, filed 13 May 2025.